Follicular lymphoma is a very diverse disease, and decisions to treat in the frontline are made based on histology, disease burden and patient symptoms. The general approach should be a ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Early diagnosis is crucial for better treatment outcomes. The article highlights the importance of recognizing early symptoms such ... cancers—leukemia and lymphoma. These cancers begin in ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...

The US regulator has cleared Kite's CD19-targeted CAR-T Yescarta (axicabtagene ciloleucel) for people with large B-cell lymphoma (LBCL) refractory to one earlier therapy, or who have relapsed ...

HIV symptoms vary by the stage of infection, known as acute HIV infection (Stage 1), chronic HIV infection (Stage 2), and AIDS (Stage 3). During primary infection, the symptoms are caused by the virus ...

Some anecdotal evidence suggests supplementation may relieve symptoms of restless legs syndrome. While research hasn’t been conclusive, one study, where subjects supplemented with either ...

13, 2024 — Why do some people develop severe flu symptoms? A study points the finger ... They found that a specific type of immune cell, called T follicular helper cells, indirectly controls ...